– CNBC
BioMarin Pharmaceutical Sees FY23 EPS $0.78-$1.03 Vs $0.95 Est.; FY23 $2.375M-$2.5M Vs $2.46B Est.
2023 Full-Year Financial Guidance (in millions, except % and EPS amounts) (Updated)
Item
2023 Guidance
Updated April 26,